// App-Quantinova.ai

P362 : MINIMAL-LOSS-CYTOMETRY FOR EVALUATION OF CEREBROSPINAL FLUID IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. SINGLE CENTER STUDY.

Researchers

Presenter

  • Michaela Novkov

Principal Investigators

  • Iveta Janotov

  • Elena Vodickov

  • Alena Houdkov

  • Jitka Hanzalov

  • Martina Vkov

  • Daniela Kulkov

  • Ester Mejstrkov

  • Lucie rmkov

  • Jan Star

Medical Centers

  • Department of Immunology,Second Faculty of Medicine, Charles University and University Hospital Motol,Prague,Tschechische Republik

  • Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

  • Department of Immunology

  • CLIP-Paediatric Haematology and Oncology,Second Faculty of Medi

  • CLIP-Paediatric Haematology and Oncology,Second Faculty of Medicine, Charles University,Prague,Tchèque, République

  • Department of Paediatric Haematology and Oncology,Second Faculty of Medicine, Charles Univ

  • Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

  • CLIP-Paediatric Haematology and Oncology,Second Faculty of Medicine, Charles University,Prague,Rep. Ceca

  • Department of Immunology,Second Faculty of Medicine, Charles University and University Hospital Motol,Prague,Tschechische Republik

  • Department of Immunology,Second Faculty of Medicine, Charles University and University Hospital Motol,Prague,Tschechische Republik

Locations

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cytokeratin 20

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 34

  • Cluster of Differentiation 19

  • Cluster of Differentiation 4

  • Protein Tyrosine Phosphatase, Receptor Type C

  • Cluster of Differentiation 5

  • Cluster of differentiation 7

  • Cluster of differentiation 8A

  • Fc gamma RIIIa

  • White Blood Cell

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A